MetLife Inc.: 52-Week High Recently Eclipsed (MET)

Shares of MetLife Inc. (NYSE:MET) traded today at $70.13, eclipsing its 52-week high. So far today approximately 1.3 million shares have been exchanged, as compared to an average 30-day volume of 4.3 million shares.

MetLife–once a mutual company before the 2000 demutualization–is the largest life insurer in the U.S. by assets and provides a variety of insurance and financial services products. Outside the United States, MetLife operates in Japan and more than 40 countries in Latin America, Asia-Pacific, Europe, and the Middle East.

MetLife Inc. (NYSE:MET) is currently priced 9.5% above its average consensus analyst price target of $63.39.

MetLife Inc. share prices have moved between a 52-week high of $70.13 and a 52-week low of $48.72 and are now trading 44% above that low price at $70.04 per share.

Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts

To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected

About IBN (InvestorBrandNetwork)

IBN consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and Code Editorial Syndication to 5,000+ broadcast outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign and the NEW normal.

For more information on IBN, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer